Boston Partners Has $192.51 Million Stock Holdings in Humana Inc. (NYSE:HUM)

Key Points

• Boston Partners has decreased its holdings in Humana Inc. by 33.8%, now owning 727,584 shares valued at approximately $192,508,000.
• In the first quarter, several other institutional investors increased their stakes in Humana, with Cary Street Partners boosting its position by 63.9%.
• Currently, Humana has a consensus rating of "Hold" from analysts, with an average target price of $281.62.

Boston Partners lowered its stake in shares of Humana Inc. (NYSE:HUM - Free Report) by 33.8% in the first quarter, according to the company in its most recent filing with the Securities and Exchange Commission (SEC). The fund owned 727,584 shares of the insurance provider's stock after selling 371,118 shares during the quarter. Boston Partners owned about 0.60% of Humana worth $192,508,000 at the end of the most recent quarter.

A number of other institutional investors and hedge funds also recently modified their holdings of HUM. Cary Street Partners Investment Advisory LLC increased its position in Humana by 63.9% during the 1st quarter. Cary Street Partners Investment Advisory LLC now owns 118 shares of the insurance provider's stock worth $31,000 after purchasing an additional 46 shares in the last quarter. Applied Finance Capital Management LLC lifted its stake in Humana by 1.7% during the first quarter. Applied Finance Capital Management LLC now owns 2,943 shares of the insurance provider's stock worth $779,000 after purchasing an additional 48 shares during the last quarter. Achmea Investment Management B.V. lifted its stake in Humana by 0.5% during the first quarter. Achmea Investment Management B.V. now owns 10,379 shares of the insurance provider's stock worth $2,746,000 after purchasing an additional 49 shares during the last quarter. Beech Hill Advisors Inc. lifted its stake in Humana by 6.1% during the first quarter. Beech Hill Advisors Inc. now owns 865 shares of the insurance provider's stock worth $229,000 after purchasing an additional 50 shares during the last quarter. Finally, Townsquare Capital LLC lifted its stake in Humana by 2.8% during the first quarter. Townsquare Capital LLC now owns 2,255 shares of the insurance provider's stock worth $597,000 after purchasing an additional 61 shares during the last quarter. Institutional investors and hedge funds own 92.38% of the company's stock.

Analysts Set New Price Targets

HUM has been the topic of several analyst reports. Cantor Fitzgerald reaffirmed a "neutral" rating and issued a $290.00 target price on shares of Humana in a research report on Thursday, May 1st. Barclays set a $275.00 target price on Humana and gave the company an "equal weight" rating in a research note on Thursday, July 31st. Wall Street Zen cut Humana from a "buy" rating to a "hold" rating in a research note on Saturday, August 2nd. Morgan Stanley decreased their price target on Humana from $290.00 to $277.00 and set an "equal weight" rating for the company in a research report on Thursday, July 31st. Finally, Robert W. Baird decreased their price objective on Humana from $300.00 to $297.00 and set a "neutral" rating for the company in a research report on Friday, July 25th. Seventeen research analysts have rated the stock with a hold rating and seven have issued a buy rating to the stock. According to data from MarketBeat.com, the company presently has an average rating of "Hold" and a consensus target price of $281.43.

Humana Price Performance

HUM stock traded up $5.39 during trading on Friday, hitting $286.73. The company had a trading volume of 1,738,591 shares, compared to its average volume of 2,075,797. The company has a fifty day moving average price of $242.70 and a two-hundred day moving average price of $253.82. The company has a current ratio of 1.95, a quick ratio of 1.95 and a debt-to-equity ratio of 0.69. The company has a market cap of $34.49 billion, a P/E ratio of 22.01, a P/E/G ratio of 1.65 and a beta of 0.44. Humana Inc. has a fifty-two week low of $206.87 and a fifty-two week high of $382.72.

Humana (NYSE:HUM - Get Free Report) last posted its quarterly earnings data on Wednesday, July 30th. The insurance provider reported $6.27 EPS for the quarter, missing analysts' consensus estimates of $6.32 by ($0.05). The business had revenue of $32.39 billion during the quarter, compared to analyst estimates of $31.85 billion. Humana had a return on equity of 13.67% and a net margin of 1.28%. Humana's revenue for the quarter was up 9.6% compared to the same quarter last year. During the same period in the prior year, the firm posted $6.96 EPS. Equities research analysts expect that Humana Inc. will post 16.47 earnings per share for the current fiscal year.

Humana Profile

Humana Inc, together with its subsidiaries, provides medical and specialty insurance products in the United States. It operates through two segments, Insurance and CenterWell. The company offers medical and supplemental benefit plans to individuals. It has a contract with Centers for Medicare and Medicaid Services to administer the Limited Income Newly Eligible Transition prescription drug plan program; and contracts with various states to provide Medicaid, dual eligible, and long-term support services benefits.